
Copenhagen-based biotech company IO Biotech seeks a listing in the US, reports Danish financial daily Børsen, referring to a filing that the firm has sent to the US Securities and Exchange Commission (SEC).
Meanwhile, Claus Andersson, partner in the venture capital fund Sunstone, which is one of the owners of IO Biotech, confirms the IPO plans to Børsen, without any further comment for the time being.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app